Follow
Anthony A. McKinney
Anthony A. McKinney
Unknown affiliation
Verified email at ethismos.com
Title
Cited by
Cited by
Year
Novastan®(brand of argatroban): a small-molecule, direct thrombin inhibitor
MJ Hursting, KL Alford, JP Becker, RL Brooks, JL Joffrion, ...
Seminars in thrombosis and hemostasis 23 (06), 503-516, 1997
1771997
Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo …
P Tran, P Skolnick, P Czobor, NY Huang, M Bradshaw, A McKinney, ...
Journal of psychiatric research 46 (1), 64-71, 2012
922012
Sustained release formulation of naltrexone
AA McKinney, GD Tollefson, R Soltero, TE Dunzo
US Patent 8,916,195, 2014
752014
Layered pharmaceutical formulations
A McKinney, G Tollefson, E Weber, R Soltero
US Patent 8,088,786, 2012
662012
Methods for administering weight loss medications
A McKinney, G Tollefson, E Weber, R Soltero
US Patent 8,722,085, 2014
542014
Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats
NM Wallingford, P Sinnayah, FP Bymaster, KM Gadde, RK Krishnan, ...
Neuropsychopharmacology 33 (12), 2922-2933, 2008
492008
Compositions and methods for reducing food cravings
A McKinney, G Tollefson, M Cowley
US Patent App. 11/602,813, 2007
472007
Compositions of an anticonvulsant and methods of using the same for reversing weight gain
A McKinney, G Tollefson, M Cowley
US Patent App. 11/622,363, 2007
432007
Compositions and methods for increasing insulin sensitivity
MA Cowley, AA McKinney, G Tollefson
US Patent 8,815,889, 2014
422014
Methods for administering weight loss medications
AA McKinney, G Tollefson, E Weber, R Soltero
US Patent 9,125,868, 2015
402015
Methods for administering weight loss medications
A McKinney, G Tollefson, E Weber, R Soltero
US Patent App. 11/937,367, 2008
382008
State-of-the-Art Review: The Preclinical and Clinical Pharmacology of Novastan (Argatroban): A Small-Molecule, Direct Thrombin Inhibitor
RP Schwarz Jr, JCP Becker, RL Brooks, MJ Hursting, JL Joffrion, ...
Clinical and Applied Thrombosis/Hemostasis 3 (1), 1-15, 1997
371997
Preparation and Use of (+)-1-(3, 4-Dichlorophenyl)-3-Azabicyclo [3.1. 0] Hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
AA McKINNEY, F Bymaster, W Piskorski
US Patent App. 13/310,694, 2012
242012
Compositions for affecting weight loss
G Tollefson, A McKinney, M Higgin, J McCall
US Patent App. 11/492,685, 2007
242007
Layered pharmaceutical formulations
A McKinney, G Tollefson, E Weber, R Soltero
US Patent 8,318,788, 2012
212012
Layered pharmaceutical formulations
A McKinney, G Tollefson, E Weber, R Soltero
US Patent 8,318,788, 2012
212012
Layered pharmaceutical formulations
A McKinney, G Tollefson, E Weber, R Soltero
US Patent 8,318,788, 2012
212012
Sustained-release formulation of zonisamide
A McKinney, G Tollefson, S Yau, R Vladyka, R Soltero
US Patent App. 11/563,618, 2007
202007
Compositions and methods for reducing food cravings
AA McKinney, G Tollefson, MA Cowley
US Patent App. 12/903,131, 2011
192011
Safety and efficacy of centanafadine sustained-release in adults with attention-deficit hyperactivity disorder: results of phase 2 studies
SB Wigal, T Wigal, M Hobart, JJ Madera, RA Baker, E Kohegyi, ...
Neuropsychiatric Disease and Treatment, 1411-1426, 2020
172020
The system can't perform the operation now. Try again later.
Articles 1–20